CASOLARI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.850
AS - Asia 2.710
EU - Europa 2.045
SA - Sud America 441
AF - Africa 42
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.108
Nazione #
US - Stati Uniti d'America 5.755
SG - Singapore 1.138
CN - Cina 793
IT - Italia 548
DE - Germania 449
BR - Brasile 366
UA - Ucraina 341
HK - Hong Kong 256
FI - Finlandia 207
TR - Turchia 196
VN - Vietnam 177
GB - Regno Unito 154
SE - Svezia 95
RU - Federazione Russa 80
MX - Messico 51
FR - Francia 40
CA - Canada 38
ID - Indonesia 38
PL - Polonia 32
AR - Argentina 27
IN - India 26
NL - Olanda 25
ZA - Sudafrica 24
BD - Bangladesh 18
ES - Italia 15
JP - Giappone 15
BE - Belgio 14
EC - Ecuador 12
IQ - Iraq 12
PY - Paraguay 11
AU - Australia 10
LT - Lituania 9
AT - Austria 8
CO - Colombia 8
MA - Marocco 8
VE - Venezuela 7
AL - Albania 5
TW - Taiwan 5
MY - Malesia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
UY - Uruguay 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
KR - Corea 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.108
Città #
Fairfield 641
Singapore 630
Woodbridge 556
Ashburn 513
Houston 390
Jacksonville 379
Santa Clara 301
Ann Arbor 281
Chandler 279
Beijing 256
Munich 256
Hong Kong 255
Seattle 229
Wilmington 220
Cambridge 205
Washington 199
Izmir 138
Nanjing 123
Helsinki 96
Los Angeles 96
Milan 88
Dallas 86
Princeton 86
Ferrara 72
New York 65
Ho Chi Minh City 57
Boardman 55
San Diego 43
Chicago 40
Dearborn 35
Hanoi 35
Shanghai 35
Rome 34
Mexico City 33
Addison 31
Warsaw 30
Nanchang 29
Jakarta 28
Turku 28
Shenyang 27
Hebei 26
São Paulo 26
Tianjin 22
Hefei 20
Jiaxing 20
Brooklyn 19
Changsha 18
Buffalo 16
London 16
Moscow 16
Mountain View 16
Guangzhou 15
Kunming 15
Toronto 15
Denver 14
Bologna 13
Bremen 13
Brussels 13
Tokyo 13
Florence 12
Redwood City 12
Auburn Hills 11
Boston 11
Frankfurt am Main 11
Jinan 11
Johannesburg 11
Montreal 11
Naples 11
Parma 11
Belo Horizonte 10
Campinas 10
Chennai 10
Jyväskylä 10
San Francisco 10
Taizhou 10
Verona 10
Atlanta 9
Dong Ket 9
Falls Church 9
Norwalk 9
Rio de Janeiro 9
Haiphong 8
Hải Dương 8
Ningbo 8
Nuremberg 8
Orange 8
Orem 8
Zhengzhou 8
Curitiba 7
Philadelphia 7
Salt Lake City 7
Stockholm 7
Amsterdam 6
Augusta 6
Baghdad 6
Da Nang 6
Lanzhou 6
Padova 6
Padua 6
Phoenix 6
Totale 7.665
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 317
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 314
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 311
Targeting Th2 cells in asthmatic airways 276
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 257
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 237
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 211
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178
Activation of NF-kappaB transcription factor in asthma death 172
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 170
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 170
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 169
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 169
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 163
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 162
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 159
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 158
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 154
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 152
Cellule staminali e patologia polmonare dell’adulto 150
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 150
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 150
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 150
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 148
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 144
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 142
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 141
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 141
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 138
Mechanisms involved in lung cancer development in COPD 134
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 130
Pathophysiology of viral-induced exacerbations of COPD 126
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 125
New drugs targeting Th2 lymphocytes in asthma 124
Increased deposition of activated complement in peripheral lung vessels of smokers 122
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 122
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 121
null 121
COPD immunopathology 121
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 119
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 119
null 118
COPD pathology in the small airways 117
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 114
null 114
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 108
null 102
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 102
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 102
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 98
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 98
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 97
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 97
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 96
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 95
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 94
null 92
null 91
null 91
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 90
null 90
null 88
null 88
Trattamento personalizzato dei pazienti con BPCO in fase stabile 88
Xanthine-Oxidase System Activation Is Required in Rhinovirus Induced Oxidant Production in Respiratory Epithelial Cells 88
Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and gro- production in bronchial epithelial cells. 86
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication 84
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 82
null 81
null 81
Inhibition of PI-3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice 79
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 79
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease 78
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 77
Definition and aetiology of infective exacerbations of COPD 74
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 73
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 73
Expression of adenosine receptors in the peripheral lung from COPD patients. 73
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease 73
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 70
SAA and lipid metabolism in IPF 69
Scavenger Receptor B1 involvement in COPD pathogenesis 68
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1 67
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia. 66
null 66
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 64
Ruolo delle infezioni virali nelle riacutizzazioni asmatiche. 63
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κb and c-Jun N-terminal kinase activation 59
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 57
null 51
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations 49
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study 45
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 42
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 39
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 37
Role of transcription factors in the pathogenesis of asthma and COPD 34
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 31
Totale 11.265
Categoria #
all - tutte 52.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.388
Totale 55.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021691 0 0 0 0 0 120 50 120 23 135 132 111
2021/2022730 26 71 70 54 24 36 26 49 22 58 85 209
2022/2023731 91 21 25 92 120 107 32 61 95 3 54 30
2023/2024353 39 45 14 6 28 55 10 17 6 10 12 111
2024/20252.025 42 52 141 49 234 223 138 154 368 214 224 186
2025/20262.645 447 238 447 616 835 62 0 0 0 0 0 0
Totale 11.265